Doctor of Osteopathy Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Batool Shukr

Internal Medicine Detroit, MI Doctor of Osteopathy

NPI 1063072064 CMS profile 11306621

2799 W. Grand Boulevard, Detroit, MI 48202

Open in the dashboard

General payments

$5,713

88 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Batool Shukr of Detroit, MI is reported in the CMS Open Payments database as having received $5,713 across 88 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,464 52
2024 General $1,301 22
2023 General $852 13
2021 General $96 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Batool Shukr
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Batool Shukr were reported at $3,464. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Batool Shukr Internal Medicine median Middle half National median
2019 $0 $159 $48–$570 $163
2020 $0 $119 $33–$402 $114
2021 $96 $135 $37–$521 $132
2022 $0 $141 $42–$496 $149
2023 $852 $149 $45–$519 $160
2024 $1,301 $154 $47–$537 $164
2025 $3,464 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $1,784 22 payments
  2. AstraZeneca Pharmaceuticals LP $774 10 payments
  3. Abiomed $559 8 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $488 11 payments
  5. Cardiva Medical, Inc. $305 7 payments
  6. Boston Scientific Corporation $267 6 payments
  7. Stryker Corporation $253 2 payments
  8. Shockwave Medical, Inc $182 2 payments
  9. Penumbra, Inc. $143 1 payment
  10. Kestra Medical Technology Services, Inc. $141 4 payments
  11. Other $817 15 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,149 76 payments
  2. Travel and Lodging $1,059 7 payments
  3. Education $505 5 payments
Products named General payments · program years 2021–2025
  1. CARDIOMEMS $1,336 18 payments
  2. LifeVest $488 11 payments
  3. ENSITE $237 1 payment
  4. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $182 2 payments
  5. Cardiva VASCADE 6/7F VCS $180 6 payments
  6. OPTIS $175 1 payment
  7. FLOWTRIEVER CATHETER, S $146 1 payment
  8. CT THROMBECTOMY SYSTEM KIT $146 1 payment
  9. Indigo System $143 1 payment
  10. Assure WCD $141 4 payments
  11. Other $1,559 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record